Impact of Fixed-Duration Oral Targeted Therapies on the Economic Burden of Chronic Lymphocytic Leukemia in Canada.

Published in: Current oncology (Toronto, Ont.) (2023)

Fixed OTT is expected to result in major reductions in cost burden over the 5-year projection, compared to continuous OTT.

Keyphrases